Latest News

Anaphylaxis Campaign is pleased to announce the appointment of Simon Williams as CEO, as of 22 November 2021.   Simon succeeds Lynne Regent, who retired in August 2021 after 13 years as Chief Executive. Simon was Head of External Affairs

The senior coroner for Cheshire, Alan Moore, has ended the inquest into the death of 12-year-old Cason Hallwood, who tragically died on Christmas Day 2020. Cason was allergic to nuts and had asthma. He died in hospital following an allergic

The Anaphylaxis Campaign was delighted to attend the annual conference of the British Society for Allergy and Clinical Immunology in Harrogate from the 6th to 9th October 2021 This was the first face-to-face conference for the BSACI in two years

At Imperial College London, our courses are run by world-leading experts and incorporate up-to-the-minute information on new research and clinical practice to ensure that what you learn is always relevant to what you do. These innovative online courses will give

The paediatric allergy group of the British Society for Allergy and Clinical Immunology have produced updated guidance for clinicians about vaccinations against COVID-19, Influenza and MMR for children with food allergy or asthma. You can read the new guidance here 

Egg allergy most commonly presents in infancy and around 1 in 50 children has an egg allergy. An updated guideline for the management of egg allergy has been announced by the British Society for Allergy and Clinical Immunology (BSACI). The

Kantar Health, an independent research agency, is collaborating with sponsoring company DBV Technologies, and with the assistance of Anaphylaxis Campaign, to conduct research on the economic burden caused by peanut allergy. In this context, Kantar Health  invite you to participate

The prevalence of peanut allergy is increasing in Western countries and is reported to be up to 3% among children.

The 2020/2021 NHS hospital admissions figures for allergy and anaphylaxis have been published. Following 7 years of a steady increase in admissions, this year’s figures show a substantial decline in both allergy and anaphylaxis hospital admissions for adults and children.